Capital Analysts, LLC Global X Fds Genomics & Biotec Transaction History
Capital Analysts, LLC
- $2.49 Billion
- Q4 2024
A detailed history of Capital Analysts, LLC transactions in Global X Fds Genomics & Biotec stock. As of the latest transaction made, Capital Analysts, LLC holds 14,893 shares of GNOM stock, worth $144,313. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,893
Previous 17,201
13.42%
Holding current value
$144,313
Previous $194,000
25.26%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding GNOM
# of Institutions
72Shares Held
3.37MCall Options Held
0Put Options Held
200-
One Capital Management, LLC Westlake Village, CA720KShares$6.97 Million0.25% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL337KShares$3.27 Million0.01% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL306KShares$2.97 Million0.0% of portfolio
-
Portland Global Advisors LLC269KShares$2.61 Million0.33% of portfolio
-
Flow Traders U.S. LLC New York, NY142KShares$1.38 Million0.06% of portfolio